True. Except that this particular result - unlike DLX’s products - is not of any great quality. Plenty of profits on asset sales taken above the line.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025